Découvrir nos portefeuilles : Investisseur PEA |  International |  Trader
Accès Membre / Client

Accueil Zonebourse  >  Actions  >  Nasdaq  >  Bruker Corporation    BRKR   US1167941087

BRUKER CORPORATION (BRKR)

6
SynthèseCotationsGraphiquesActualitésAnalysesAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
Métier
Manufactures scientific instruments

Bruker Corp. designs, manufactures, services and markets proprietary life science and materials research systems based on its technology platforms, including magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology and infrared and Raman molecular spectroscopy technologies.

It sells a broad range of field analytical systems for chemical, biological, radiological, nuclear and explosive, or CBRNE, detection.

The company also develops and manufactures low temperature and high temperature superconducting wire products and superconducting wire and superconducting devices for use in advanced magnet technology, physics research and energy applications.

It organized into four operating segments: the Bruker BioSpin group, the Bruker CALID group, the Bruker MAT group, and Bruker Energy & Supercon Technologies.

The Bruker BioSpin group segment is in the business of designing, manufacturing and distributing enabling life science tools based on magnetic resonance technology.

The Bruker CALID group segment is in the business of designing, manufacturing, and distributing mass spectrometry and chromatography instruments and solutions for life sciences, including proteomics, metabolomics, and clinical research applications.

Its mass spectrometry and chromatography instruments also provide solutions for applied markets that include food safety, environmental analysis and petrochemical analysis.

Bruker CALID also designs, manufactures, and distributes various analytical instruments for CBRNE detection and research, as well as analytical, research and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.

The Bruker MAT group segment is in the business of manufacturing and distributing advanced analytical X-ray technologies and spark-optical emission spectroscopy, atomic force microscopy and stylus and optical metrology instrumentation used in non-destructive molecular, materials and elemental analysis.

The Bruker Energy & Supercon Technologies segment is in the business of developing and producing low temperature superconductor and high temperature superconductor materials for use in advanced magnet technology and energy applications as well as linear accelerators, accelerator cavities, insertion devices, other accelerator components and specialty superconducting magnets for physics and energy research and a variety of other scientific applications.

The company was founded by Günther Laukien and Emil Bruker in 1960 and is headquartered in Billerica, MA.

Nombre d'employés : 6 200 personnes.
Ventes par activité
20122013Delta
USD (en Millions)%USD (en Millions)%
Scientific Instruments1 66693%1 71092.9% +2.54%
Energy & Supercon Technologies136,207.6%147,408% +7.6%
Eliminations-10,90-0.6%-17,50-1%-
Ventes par région
20122013Delta
USD (en Millions)%USD (en Millions)%
Asia Pacific570,6031.9%529,1028.8% -7.84%
Rest of Europe531,2029.7%583,7031.7% +8.99%
United States377,4021.1%359,7019.6% -4.92%
Germany174,809.8%188,9010.3% +7.46%
Other137,407.7%178,009.7% +22.81%
Dirigeants
Nom AgeDepuisTitre
Frank H. Laukien, PhD541991Chairman, President & Chief Executive Officer
Charles F. Wagner Jr., MBA462010Chief Financial Officer & EVP-Administration
Richard D. Kniss, MBA732003Independent Director
William A. Linton662000Lead Independent Director
Bernhard Wangler MBA, CPA622000Independent Director
Joerg C. Laukien602005Director
Richard M. Stein621992Secretary & Director
Wolf-Dieter Emmerich, PhD742007Independent Director
Brenda J. Furlong, MBA662007Independent Director
Richard A. Packer, MBA562007Independent Director
Actionnaires
Nom Actions%
Frank H. Laukien, PhD 39 325 452 23,3%
T. Rowe Price Associates, Inc. 23 445 410 13,9%
Joerg C. Laukien 18 198 445 10,8%
The Vanguard Group, Inc. 6 917 662 4,11%
Fidelity Management & Research Co. 4 850 442 2,88%
Harris Associates LP 4 620 264 2,74%
Wellington Management Co. LLP 4 066 478 2,41%
Artisan Partners LP 4 030 061 2,39%
BlackRock Fund Advisors 3 909 962 2,32%
OppenheimerFunds, Inc. 3 023 050 1,79%
Secteur
Santé
Services de santé
 Equipements et fournitures en soins de santé
  Equipement et technologie médicale avancés
   Equipement et technologie médicale de pointe - NCA
Publicité
Secteur Equipement et technologie médicale avancés
CroissanceRentabilité
THERMO FISHER SCI..
FRESENIUS SE & CO..
ILLUMINA, INC.
PHILIPS
CERNER CORPORATIO..
BOSTON SCIENTIFIC..
INTUITIVE SURGICA..
EDWARDS LIFESCIEN..
OLYMPUS CORP
WATERS CORPORATIO..
RESMED INC.
RESMED INC. (CHES..
VARIAN MEDICAL SY..
HOLOGIC, INC.
PERKINELMER, INC.
SIRONA DENTAL SYS..
ALERE INC
CEPHEID
GN STORE NORD A/S
ELEKTA PUBL AB
Secteur Equipement et technologie médicale avancés
Bruker Corporation : Connexions
ZOLL Lifecor Corp.
Nixon Peabody LLP
Analytical & Life Science Systems Association
Bruker Optics GmbH
Zoo New England
The Rivers School Corp.
Brucker BioSpin SAS
Harvard University
Boston Cares
Good Start Genetics, Inc.
University of Bayreuth
Promega Corp.
Angiotech Pharmaceuticals, Inc.
The Biopharmaceutical Technology Center Institute
Bruker Daltonics, Inc.
Wisconsin Technology Council
Bruker BioSpin SRL
Kanzlei Wangler
Bruker AXS, Inc.
Bruker BioSpin GmbH
Bruker Detection Corp.
Bruker BioSpin MRI GmbH
Analytica International, Inc.
Bruker Elektronik GmbH
Athene Annuity & Life Co.
Bruker BioSpin Corp.
ZOLL Medical Corp.
Bruker Biospin Group
University of Massachusetts
Techneon AG
Massachusetts Medical Device Development Center
© 2015 People , Fundamentals and Ownership   
Rechercher
Contactez-nous
+33 (0)4 78 30 41 42
Rejoignez
127 126 membres
Cotations dynamiques  
ON
| OFF